Hypera S.A. Reg.Shs (Spons.ADRs)/1 o.N.

Sector and Industry

Healthcare, Biopharmaceuticals

Performance (1Y)

5.11%

Market Cap

-

P/E Ratio

12.84

Dividend Yield

3.23 %

Earnings per Share

0.30 €

Peer Group

Company NameMarket CapRevenue Last Reported YearP/E RatioProfit Growth 1YLast PricePrevious Trading Day Change
Eli Lilly and Company864.54 Bil.57.78 Bil.46.82
+86.88 %
0.00
-
Johnson & Johnson425.70 Bil.83.48 Bil.18.82
+82.71 %
0.00
-
AbbVie Inc.343.94 Bil.54.21 Bil.96.78
-5.29 %
0.00
-
Roche Holding AG286.62 Bil.65.80 Bil.20.72
+58.45 %
0.00
-
AstraZeneca PLC244.91 Bil.52.09 Bil.27.55
+39.41 %
0.00
-
NOVARTIS AG 224.76 Bil.48.44 Bil.18.30
+12.45 %
0.00
-
Merck & Co. Inc.221.79 Bil.57.55 Bil.14.46
+2.25 %
0.00
-
Novo-Nordisk AS B193.52 Bil.41.49 Bil.14.11
+1.54 %
0.00
-
Amgen Inc.150.16 Bil.32.57 Bil.23.01
+80.77 %
0.00
-
Gilead Sciences Inc.129.70 Bil.26.10 Bil.18.10
+1,599.93 %
0.00
-

Facts & figures

Price data

TRADE PLATFORMBörse Stuttgart (XSTU)
LAST PRICE3.34 G0 Units
PRICE DETERMINATION TIME07/23/2026 / 07:04:49 PM
DAILY VOLUME (UNITS)0
DAILY HIGH / LOW3.423.34
PREV. DAY'S PRICE3.34 (07/22)
CHANGE DAY BEFORE
+0.00
0.00 %
52 WEEK HIGH / LOW4.38 (01/29)2.7 (10/14)
More Price Information

Key Figures (in EUR)

20232024202520262027
EARNINGS PER SHARE
0.480.360.30--
DIVIDENDS PER SHARE
0.090.130.12--
DIVIDEND YIELD IN %
1.32 %4.76 %3.23 %--
DIVIDEND GROWTH IN %
-36.48 %43.92 %-4.40 %--
PRICE - EARNINGS RATIO
14.267.5312.84--
PRICE - BOOK RATIO
1.990.961.20--
PRICE - SALES RATIO
2.991.372.01--
PRICE - CASH FLOW RATIO
21.677.5410.82--
Further Key Figures

Master Data

WKN
A2JETE
ISIN
US44914U1060
SYMBOL
HM6A
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Equity
DENOMINATION
Hypermarcas
INDEX MEMBERSHIP
-
TRADING SEGMENT
-
TRADING HOURS
07:30:00 AM - 10:00:00 PM
TRADING CURRENCY
Euro
NOMINAL CURRENCY
-
SETTLEMENT CURRENCY
Euro
SECTOR AND INDUSTRYHealthcare, Biopharmaceuticals
NUMBER OF SHARES
-
MARKET CAPITALISATION
-

Performance overview

1W1M3M6M1Y3Y5YYTD
PERFORMANCE
-0.60 %
2.45 %
-11.17 %
-14.80 %
-5.11 %
-58.25 %
-35.77 %
12.08 %
HIGH3.583.624.044.384.388.0510.104.38
LOW3.303.263.263.222.702.082.083.22

Dividende

pro Aktie

Company profile

Hypera SA is a pharmaceutical company, which engages in the manufacture and distribution of medical and cosmetics products. It operates through the following segments: Prescription Products, Consumer Health, Similar and Generic Drugs, Skincare, and Institutional Market. The company was founded by João Alves de Queiroz Filho on December 1, 2001 and is headquartered in Sao Paulo, Brazil.

Shareholder Structure (Top 10)

AnteilName
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available

Analyst Rating

Ø-Target Price DistanceNot Available
Current Price
Not Available
Ø-Target Price
Not Available
Average ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0

Company Events

No company events available.